Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,513,000 | 11,862,000 | 6,243,000 | 2,928,000 | 1,585,000 |
| Depreciation Amortization | 607,000 | 707,000 | 816,000 | 892,000 | 927,000 |
| Income taxes - deferred | 422,000 | 163,000 | 1,430,000 | -416,000 | -236,000 |
| Accounts receivable | -270,000 | 227,000 | -360,000 | -458,000 | 444,000 |
| Accounts payable and accrued liabilities | 315,000 | N/A | 253,000 | 141,000 | -349,000 |
| Other Working Capital | -29,000 | 974,000 | 455,000 | -461,000 | -491,000 |
| Other Operating Activity | -1,067,000 | -9,868,000 | -5,130,000 | 527,000 | 203,000 |
| Operating Cash Flow | $4,491,000 | $4,065,000 | $3,707,000 | $3,153,000 | $2,083,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,823,000 | -3,489,000 | 138,000 | 756,000 | 762,000 |
| PPE Investments | -424,000 | -173,000 | -405,000 | -526,000 | -502,000 |
| Net Acquisitions | -762,000 | -2,232,000 | 4,339,000 | -432,000 | 226,000 |
| Sale Of Investment | 3,197,000 | 2,075,000 | 1,007,000 | N/A | N/A |
| Other Investing Activity | 0 | -561,000 | 0 | 0 | -280,000 |
| Investing Cash Flow | $-3,812,000 | $-4,380,000 | $5,079,000 | $-202,000 | $206,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -33,000 | -26,000 | -1,688,000 | -33,000 | 30,000 |
| Debt Issued | 6,000 | 1,683,000 | 1,580,000 | N/A | 2,506,000 |
| Debt Repayment | -936,000 | -212,000 | -229,000 | -1,300,000 | -3,796,000 |
| Common Stock Issued | 252,000 | 827,000 | 5,000 | 333,000 | 170,000 |
| Common Stock Repurchased | -576,000 | 0 | 0 | N/A | N/A |
| Dividend Paid | -2,202,000 | -2,483,000 | -2,461,000 | -2,213,000 | -2,199,000 |
| Other Financing Activity | 146,000 | 194,000 | 211,000 | 0 | -62,000 |
| Financing Cash Flow | $-3,343,000 | $-17,000 | $-2,582,000 | $-3,213,000 | $-3,351,000 |
| Exchange Rate Effect | 14,000 | 39,000 | -29,000 | 45,000 | 30,000 |
| Beginning Cash Position | 7,683,000 | 7,976,000 | 1,801,000 | 2,018,000 | 3,050,000 |
| End Cash Position | 5,033,000 | 7,683,000 | 7,976,000 | 1,801,000 | 2,018,000 |
| Net Cash Flow | $-2,650,000 | $-293,000 | $6,175,000 | $-217,000 | $-1,032,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,491,000 | 4,065,000 | 3,707,000 | 3,153,000 | 2,083,000 |
| Capital Expenditure | -424,000 | -730,000 | -941,000 | -843,000 | -785,000 |
| Free Cash Flow | 4,067,000 | 3,335,000 | 2,766,000 | 2,310,000 | 1,298,000 |